A critical appraisal of one‐stage and chromogenic assays of factor VIII activity

Summary Accurate and precise potency determination by manufacturers of different types of factor VIII product (plasma‐derived and recombinant FVIII [rFVIII]) is vital to clinicians and patients using FVIII concentrates. A separate, but related, requirement is ascertaining the FVIII activity levels i...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of thrombosis and haemostasis Vol. 14; no. 2; pp. 248 - 261
Main Authors:	Peyvandi, F., Oldenburg, J., Friedman, K. D.
Format:	Journal Article
Language:	English
Published:	England Elsevier Limited 01-02-2016
Subjects:	activated partial thromboplastin time assay Biomarkers - blood Blood Coagulation - drug effects Blood Coagulation Tests Chromogenic Compounds Drug Monitoring - methods factor VIII Factor VIII - pharmacokinetics Factor VIII - standards Factor VIII - therapeutic use hemophilia A Hemophilia A - blood Hemophilia A - diagnosis Hemophilia A - drug therapy Hemostatics - standards Hemostatics - therapeutic use Humans Observer Variation Predictive Value of Tests Quality Control Reagent Kits, Diagnostic Reproducibility of Results hemophilia A activated partial thromboplastin time assay factor VIII blood coagulation tests
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!